<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085083" disease_type="Disease or Syndrome" abbrv="OHSS">Ovarian hyperstimulation syndrome</z:e> is a serious complication of ovulation induction and has a diverse clinical spectrum from <z:hpo ids='HP_0000969'>edema</z:hpo> to <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibody</z:hpo> syndrome, one of the well known <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable states</z:e>, can be also manifested as an arterial or <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> and recurrent <z:hpo ids='HP_0005268'>spontaneous abortion</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Sometimes a patient with <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> might not notice a <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriage</z:e> and seek for assisted reproduction treatment, which harbors a chance of developing <z:e sem="disease" ids="C0085083" disease_type="Disease or Syndrome" abbrv="OHSS">ovarian hyperstimulation syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>If this happens, the <z:e sem="disease" ids="C0085083" disease_type="Disease or Syndrome" abbrv="OHSS">ovarian hyperstimulation syndrome</z:e> can exacerbate the thrombotic complication of underlying <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome, resulting in a catastrophic vascular event </plain></SENT>
<SENT sid="4" pm="."><plain>The authors experienced a case of middle cerebral artery <z:mpath ids='MPATH_124'>infarct</z:mpath>, which developed during <z:e sem="disease" ids="C0085083" disease_type="Disease or Syndrome" abbrv="OHSS">ovarian hyperstimulation syndrome</z:e> in a 33-yr-old woman with a previous history of fetal loss </plain></SENT>
<SENT sid="5" pm="."><plain>An elevated titer of anticardiolipin antibodies was noticed and persisted thereafter </plain></SENT>
<SENT sid="6" pm="."><plain>The authors suggest screening tests for the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> before controlled ovarian hyperstimulation </plain></SENT>
</text></document>